A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
According to a new Cell study, extra DNA scooped up and copied alongside cancer-causing genes helps keep tumors going — elements that could represent new drug targets for brain tumors and other cancers notoriously difficult to treat.
As UC San Diego Athletics steps up to NCAA Division I competition level, they do so with another team behind them: UC San Diego Health, now their Official Health Care Provider.
Using HIV genetic data, researchers discovered that transgender women in Los Angeles are at higher risk of being in an HIV transmission network than men who have sex with men. In addition, cisgender men in these clusters should be considered at higher risk for HIV than previously thought.
More than 120 UC San Diego Health physicians have been named “Top Docs” in the 2019 San Diego Magazine “Physicians of Exceptional Excellence” survey, an annual opportunity for doctors across the region to vote for much-admired colleagues.
Three University of California San Diego researchers have received prestigious awards through the National Institutes of Health (NIH) High-Risk, High-Reward Research Program, including the Pioneer Award, the program’s top honor.
UC San Diego researchers suggest that prolonged exposure to a pair of antioxidant proteins may contribute to enlargement of the liver and fatty liver diseases.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the spread of pancreatic cancer and increase survival in animal models.
